Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases

Clinical Hemorheology and Microcirculation

Volumn 42, Issue 1, 2009, Pages 19-28

  Horvath, Beata ^a   Szapary, Laszlo ^a   Debreceni, Laszlo ^a   Feher, Gergely ^a   Kenyeres, Peter ^a   Fulop, Adrienn ^a   Battyani, Istvan ^a   Toth, Kalman ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Endothelial dysfunction; Folic acid; Hemorheological parameters; Homocysteine; Platelet aggregation; Vitamin B12; Vitamin B6

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; NITRATE; PIRACETAM; PLACEBO; PYRIDOXINE; STATIN; TRIACYLGLYCEROL; VINPOCETINE; VON WILLEBRAND FACTOR; 2 (4 BIPHENYLYL)BUTYRIC ACID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HUMAN; LIPID BLOOD LEVEL; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOCYTE AGGREGATION; VASCULAR DISEASE; VASODILATATION; AGED; BLOOD; CAROTID ARTERY OBSTRUCTION; DRUG COMBINATION; ERYTHROCYTE DEFORMABILITY; INTIMA; MIDDLE AGED; PATHOLOGY; TUNICA MEDIA;

AGED; ATHEROSCLEROSIS; CAROTID STENOSIS; DRUG COMBINATIONS; ERYTHROCYTE DEFORMABILITY; FEMALE; FOLIC ACID; HEMORHEOLOGY; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; TUNICA INTIMA; TUNICA MEDIA; VASODILATION; VITAMIN B 12; VITAMIN B 6; VITAMIN E; VON WILLEBRAND FACTOR;

EID: 67651153011     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1182     Document Type: Article

References (34)

1. M. Amato, P. Montorsi, A. Ravani, E. Oldani, S. Galli, P.M. Ravagnani, E. Tremoli and D. Baldassarre, Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings, Eur. Heart J. 28 (2007), 2094-2101.
2. A.D. Blann, Endothelial cell damage and homocysteine, Atherosclerosis 94 (1992), 89-91.
3. K.H. Bønaa, I. Njølstad, P.M. Ueland, H. Schirmer, A. Tverdal, T. Steigen, H. Wang, J.E. Nordrehaug, E. Arnesen and K. Rasmussen; NORVIT Trial Investigators, Homocysteine lowering and cardiovascular events after acute myocardial infarction, N. Engl. J. Med. 354 (2006), 1578-1588.
4. B. Boneu, M. Abbai, J. Plante and R. Bierme, Factor VIII complex and endothelial damage, Lancet 305 (1975), 1430.
5. L.E. Brattstrom, J.O. Jeppson, B. Israelsson and B.L. Hultberg, Folic acid - an innocuous means to reduce plasma homocysteine, Scand. J. Clin. Lab. Invest. 48 (1988), 215-221.
6. J.C. Chambers, A. McGregor, J. Jean Marie and J.S. Kooner, Acute homocysteinaemia and endothelial dysfunction, Lancet 351 (1998), 36-37.
7. S. Chien, J. Dormandy, E. Ernst and A. Matrai, Clinical Hemorheology, Martinus Nijhoff Publishers, Dordrecht, 1987.
8. A. Clauss, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol. 17 (1957), 237-246.
9. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A. Creager, J. Deanfield, H. Drexler, M. Gerhard-Herman, D. Herrington, P. Vallance, J. Vita and R. Vogel, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force, J. Am. Coll. Cardiol. 39 (2002), 257-265.
10. A.M.T. Engbersen, D.G. Franken, G.H.J. Boers, E.M. Stevens, F.J. Trijbels and H.J. Blom, Thermolabile 5,10-methylene tetrahydrofolate reductase as a cause of mild hyperhomocysteinaemia, Am. J. Hum. Genet. 56 (1995), 142-150.
11. B.E. Fischer, K.B. Thomas and F. Dorner, von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems, Thromb. Res. 91 (1998), 39-40.
12. E.S. Ford, S.J. Smith, D.F. Stroup, K.K. Steinberg, P.W. Mueller and S.B. Thacker, Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies, Int. J. Epidemiol. 31 (2002), 59-70.
13. A.M. Gori, A.M. Corsi, S. Fedi, A. Gazzini, F. Sofi, B. Bartali, S. Bandinelli, G.F. Gensini, R. Abbate and L. Ferrucci, A proinflammatory state is associated with hyperhomocysteinemia in the elderly, Am. J. Clin. Nutr. 82 (2005), 335-341.
14. D. Hackam, J.C. Peterson and J.D. Spence, What level of plasma homocyst(e)ine should be treated: Effects of vitamin therapy on progression of carotid atherosclerosis in patient with homocyst(e)ine levels above and below 14 mmol/L, Am. J. Hypertens. 13 (2000), 105-110.
15. L.A. Harker, R. Ross and J.A. Glomset, The role of endothelial cell injury and platelet response in atherogenesis, Thromb. Haemostas. 39 (1978), 312-321.
16. 12 to any folate fortification or supplement, Am. J. Clin. Nutr. 65 (1997), 572-573.
17. B. Horvath, Zs. Marton, R. Halmosi, T. Alexy, L. Szapary, J. Vekasi, Zs. Biro, T. Habon, G. Kesmarky and K. Toth, In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine, Clin. Neuropharmacol. 25 (2002), 37-42.
18. G. Kesmarky, K. Toth, L. Habon, G. Vajda and I. Juricskay, Hemorheological parameters in coronary artery disease, Clin. Hemorheol. Microcirc. 18 (1998), 245-251.
19. H.J. Klose, E. Volger, H. Brechtelsbauer, L. Heinich and H. Schmid-Schonbein, Microrheology and light transmission of blood, Pflugers Arch. 333 (1972), 126-139.
20. W. Koening and E. Ernst, The possible role of hemorheology in atherothrombogenesis, Atherosclerosis 94 (1992), 93-107.
21. S. Laurent, P. Lacolley, P. Brunel, B. Laloux, B. Pannier and M. Safar, Flow-dependent vasodilation of brachial artery in essential hypertension, Am. J. Physiol. 258 (1990), 1004-1011.
22. S.R. Lentz, R.N. Rodionov and S. Dayal, Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA, Atherosclerosis Suppl. 4 (2003), 61-65.
23. J. Loscalzo, Homocysteine trials - Clear outcomes for complex reasons, N. Engl. J. Med. 354 (2006), 1-3. Available at: www.nejm.org.
24. Zs. Marton, G. Kesmarky, J. Vekasi, A. Cser, R. Russai, B. Horvath and K. Toth, Red blood cell aggregation measurements in whole blood and fibrinogen solutions by different methods, Clin. Hemorheol. Microcirc. 24 (2001), 75-83.
25. A. Natali, A. L'Abbate and E. Ferrannini, Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality, Eur. Heart J. 24 (2003), 639-648.
26. E. Lonn, S. Yusuf, M.J. Arnold, P. Sheridan, J. Pogue, M. Micks, M.J. McQueen, J. Probstfield, G. Fodor, C. Held and J. Genest Jr., Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators, Homocysteine lowering with folic acid and B vitamins in vascular disease, N. Engl. J. Med. 354 (2006), 1567-1577.
27. P.M. Ridker, C.H. Hennekens, J.E. Buring and N. Rifai, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N. Engl. J. Med. 342 (2000), 386-843.
28. S.J. Rim, H. Leong-Poi, J.R. Lindner, K. Wei, N.G. Fisher and S. Kaul, Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity, Circulation 104 (2001), 2704-2709.
29. Y. Schwammenthal and D. Tanne, Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials, Lancet Neurol. 3 (2004), 493-495.
30. J. Selhub, P.F. Jacques, A.G. Bostom, P.W. Wilson and I.H. Rosenberg, Relationship between plasma homocysteine and vitamin status in the Farmingham study population. Impact of folic acid fortification, Public Health Rev. 28 (2000), 117-145.
31. 10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study, Eur. Heart J. 28 (2007), 2249-2255.
32. M. Verhaar, R.M.F. Wever, J.J.P. Kastelein, T. Dam, H.A. Koomans and T.J. Rabelink, 5-methyltetrahydrofolate, the active form of folic acid, restores endothel function in familial hypercholesterolemia, Circulation 97 (1998), 237-241.
33. J.F. Viles Gonzales, S.X. Anand, C. Valdiviezo, U. Zafar, R. Hutter, J. Sanz, T. Rius, M. Poon, V. Fuster and J.J. Badimon, Update in atherothrombotic disease, Mt. Sinai J. Med. 71 (2004), 197-208.
34. E.S. Zegers and F.W.A. Verheugt, Hotline sessions of the 29th European Congress of Cardiology, Eur. Heart J. 28 (2007), 2799-2802.